Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
1445910-96-5
|
| gptkbp:clinicalTrialPhase |
Phase II/III
|
| gptkbp:developedBy |
gptkb:Bayer
|
| gptkbp:hasMolecularFormula |
C26H26FN5O3
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rogaratinib
|
| gptkbp:indication |
gptkb:urothelial_carcinoma
gptkb:cancer solid tumors |
| gptkbp:IUPACName |
N-(3,5-dimethoxyphenyl)-N'-(5-fluoro-1H-indazol-3-yl)urea
|
| gptkbp:mechanismOfAction |
FGFR inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:synonym |
BAY 1163877
BAY-1163877 |
| gptkbp:target |
gptkb:FGFR3
gptkb:FGFR1 gptkb:FGFR4 gptkb:FGFR2 |
| gptkbp:bfsParent |
gptkb:CD332
|
| gptkbp:bfsLayer |
7
|